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Results: Loss of a5 integrin expression was related to chondrocyte
dedifferentiation in the osteoarthritic articular cartilage, while a1, a2
and a3 integrin expression increased in ﬁbrous areas in osteoarthritic
cartilage. The aV integrin was expressed in hyperthrophic cartilage
and increased in the articular cartilage of osteoarthritic rats, where
bone was developed and neovascularization was observed. The effect of
GDF-5 (growth differentiation factor 5) and BMP-7 (bone morphogenetic
protein 7) on integrins expression during chondrocytes differentiation
was also analyzed. A micromasses culture system of mouse embryo
mesenchymal cells, were treated with GDF-5 or BMP-7 for 4 and 6 days.
The expression of integrins was analyzed by immunohistochemistry.
GDF-5 induced the expression of a5 sub-unit while BMP-7 induced
the expression of aV sub-unit. This suggests a switch in the signal
for chondral differentiation towards hypertrophy, where GDF-5 could
keep the state of the articular chondrocyte and BMP-7 would induce
hypertrophy. The typical chondrocyte phenotype in the articular cartilage
is preserved due to the presence of Indian hedgehog (Ihh), which is
dependent on a5 integrin and GDF-5 to keep the articular cartilage and
prevent hypertrophy. This was supported by decrease of Ihh expression in
articular cartilage during OA. Treating mouse knees organ cultures with
Cyclopamine an Ihh signaling inhibitor, articular cartilage ossiﬁcation
was observed similarly with OA rat knees, probably by a process
apparently similar to endochondral ossiﬁcation.
Conclusions: The typical chondrocyte phenotype in the articular
cartilage is preserved due to the presence of Indian hedgehog (Ihh),
which is dependent on a5 integrin and GDF-5 to keep the articular
cartilage phenotype and prevent hypertrophy and OA.
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ALARMINS S100A8 AND S100A9 ELICIT AN ENHANCED CATABOLIC
RESPONSE IN CHONDROCYTES FROM OSTEOARTHRITIS PATIENTS
THAT IS TOLL LIKE RECEPTOR 4 DEPENDENT
R.F. Schelbergen1, A.B. Blom1, M.H. van den Bosch1, A. Sloetjes1,
W. Schreurs2, T. Vogl3, J. Roth3, W.B. van den Berg1, P.L. van Lent1. 1Dept.
Rheumatology, Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands;
2Dept. Orthopaedics, Radboud Univ. Nijmegen Med. Ctr., Nijmegen,
Netherlands; 3Inst. of Immunology, Univ. of Muenster, Muenster, Germany
Purpose: S100A8 and S100A9 are two Ca2+-binding proteins classiﬁed
as damage associated molecular patterns (DAMPs) or alarmins that
are found in high amounts in the synovial ﬂuid of osteoarthritis (OA)
patients. Previously, we found that S100A8 and S100A9 are associated
with cartilage degradation in murine collagenase-induced OA. We also
showed that S100A8 and S100A9 stimulate expression and activity of
matrix metalloproteinases (MMPs) and pro-inﬂammatory cytokines in
murine chondrocytes. In the current study, we investigated whether and
via which receptor S100A8 and/or S100A9 can have a catabolic effect on
chondrocytes from OA patients.
Methods: Using immunohistochemistry, we stained for S100A8 and
S100A9 protein, MMPs and a cartilage breakdown epitope speciﬁc for
MMPs (VDIPEN) in cartilage from OA donors. Isolated chondrocytes or
explants from OA and non-OA donors were stimulated with S100A8
and/or S100A9. mRNA and protein levels of MMPs, cytokines and
cartilage matrix molecules were determined with RT-qPCR and Luminex.
For receptor blocking studies, speciﬁc inhibitors for Toll-like receptor
4 (TLR4) (intracellular TAK242) and RAGE and carboxylated glycans
(blocking antibodies) were used.
Results: In cartilage of OA patients, localisation of S100A8 and S100A9
protein was found close to chondrocytes and was associated with
proteoglycan (PG) depletion, MMP1 and -3 and VDIPEN expression.
Stimulation of chondrocytes with S100A8 and S100A9 caused a
signiﬁcant upregulation of MMP1, -3, -9 and -13 at the mRNA (4.7-fold
mean increase) and the protein level (3.0-fold mean increase). Moreover,
S100A8 and S100A9 caused a huge increase in cytokine and chemokine
expression. IL-6, IL-8 andMCP-1 were all greatly increased by S100A8 and
S100A9 at both the mRNA (19.7-fold mean increase) as well as the protein
level (28.8-fold mean increase). Thereby, the expression of anabolic
markers (aggrecan and collagen type II) was signiﬁcantly reduced at the
mRNA level (2.7-fold mean decrease). Together, upregulation of MMPs
and cytokines and downregulation of production of cartilage matrix
molecules favor cartilage loss by the OA chondrocyte.
Blocking TLR4 inhibited the upregulation of MMPs, IL-6, IL-8, MCP-1
and collagen type II by S100A9 in OA chondrocytes. In contrast, the
blocking of carboxylated glycans and RAGE did not alter the S100-effects.
Finally, the catabolic effect of S100A8 and S100A9 was signiﬁcantly more
pronounced in chondrocytes from OA patients when compared to non-
OA. TLR4 mRNA expression was enhanced in OA chondrocytes, which
might be the underlying mechanism of increased sensitivity.
Conclusions: S100A8 and S100A9 have a catabolic effect on human
chondrocytes that is dependent on TLR4. OA chondrocytes are more
sensitive for S100-stimulation than normal chondrocytes.
This study underlines the potential of S100A8 and S100A9 as mediators
of cartilage damage during OA.
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F-SPONDIN MEDIATES CATABOLIC EFFECTS ON ARTICULAR
CHONDROCYTES VIA ITS THROMBOSPONDIN REPEAT (TSR) DOMAIN
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for Joint Diseases, New York, NY, USA
Purpose: We have previously shown that the thrombospondin-related,
extracellular matrix protein, F-spondin, is upregulated in osteoarthritis
(OA), and induces the production of catabolic mediators, PGE2 and MMP-
13 in cartilage explants in a TGF-b dependent manner. In this study,
we characterize the role of individual protein domains of F-spondin in
modulating its catabolic effects in chondrocytes.
Methods: OA chondrocytes were harvested from tibial cartilage obtained
from OA patients with end-stage disease undergoing knee replacement
surgery. Transient transfections were performed using TransIT-LT1
reagent (Mirus) and cDNAs encoding full length (FS1) or a truncated
C-terminal (FS7) portion of F-spondin coding sequence. Levels of TGF-b1
(R&D systems) and PGE2 (Cayman Chemical) were determined by ELISA,
MMP-13 expression was measured by qRT-PCR (Applied Biosystems).
TGF-b activity was also measured in conditioned media supernatants
by incubation with mink lung epithelial cells (MLEC) expressing a TGF-
b-responsive luciferase reporter.
Results: Consistent with our previous observations of the effects
of intact F-spondin in cartilage explants, overexpression of FS1 in
cultured OA chondrocytes from 3 patients increased expression levels
of MMP-13 ~100% compared to mock-transfected controls. Similarly,
FS1 also increased PGE2 levels by 25% (p < 0.05). Both effects could be
mimicked by transfection with a construct encoding only the c-terminal
TSR repeat domain FS7; MMP-13 and PGE2 levels were elevated by
FS7 above control vector transfected cultures, ~50% (p < 0.005) and
71% (p < 0.05), respectively. Since the F-spondin TSR domain harbors
consensus sequences for latent TGF-b activation (WxxW and KRFK),
we tested whether F-spondin overexpression increases TGF-b levels
and activity in chondrocyte cultures. In OA chondrocytes, TGF-b levels
in culture supernatants were increased 30% by FS1 and 70% by FS7.
Similarly, measurement of active TGF-b using MLEC reporter cells showed
that FS1 and FS7-transfected culture media supernatants stimulated
luciferase activity 30% and 100%, respectively (p < 0.05). Evidence of
enhanced activation of TGF-b was also demonstrated by increased SMAD
signaling. Immunoblot of FS treated chondrocytes showed increased
phosphorylation of SMAD 1, 5, 8 relative to mock transfected cells.
Similarly, both FS1 and FS7 stimulated expression of a SMAD-luciferase
reporter in OA chondrocytes.
Conclusions: Our data provide evidence that F-spondin, via its TSR
domain, can act as a latent TGF-b-activating protein and enhance the
catabolic activity of chondrocytes via induction of MMP-13 and PGE2. The
TSR domain of F-spondin may therefore represent a novel therapeutic
target for slowing cartilage breakdown in OA.
253
INHIBITING CALCINEURIN ACTIVITY UNDER PHYSIOLOGICAL
CONDITIONS SELECTIVELY PREVENTS ARTICULAR CHONDROCYTE
HYPERTROPHY
A.E. van der Windt, E. Haak, J.A. Verhaar, H. Weinans, H. Jahr. Erasmus
MC, Rotterdam, Netherlands
Purpose: Proliferation and hypertrophic differentiation of chondrocytes
as well as extracellular matrix (ECM) mineralization and chondrocytes
apoptosis occur during the course of osteoarthritis (OA). OA is
further characterized by an imbalanced production of ECM-degrading
enzymes such as matrix metalloproteinases (MMPs) and aggreganases
(ADAMTS’), which deplete major structural components like collagens
(COLs) and proteoglycans (PGs, e.g. aggrecan) from the ECM. Both
chondrogenic markers are crucial to biomechanical strength and
